Achim Newrzella


Achim joined the CG Results Healthcare team in 2015. Achim has a BSc in Biochemistry from the University of Birmingham and completed a PhD looking at the identification and culture of prostate cancer stem cells from UCL.

He also spent a brief period at Bayer Healthcare, working on process development and optimisation in biologics manufacturing.

Outside work Achim is a keen squash player, competing nationally and internationally.

Latest Insights

10th November 2021

CDMO Market Update

We are pleased to share with you the CDMO Market Update – November 2021, where we analyse global M&A activity and public market valuations in the CDMO sector. H1 2021 was an exceptional start to the year with 48 deals in total in the CDMO sector, almost reaching the total annual transactions in the previous four […]

22nd November 2019

Outsourced Pharmaceutical Manufacturing 2020

Outsourced Pharmaceutical Manufacturing 2020: Current Trends & Future Prospects In our latest analysis of the commercial and clinical contract manufacturing market, we predict the sector to grow at a CAGR of 6.8% to c. $117bn in 2023, with certain sub-sectors such as viral vector and pre-filled syringe manufacturing achieving significant double-digit growth. The Contract Development […]

20th September 2018

Biosimilars: prospects and challenges

The adoption of biosimilars varies from country to country, which is invariably linked to regulatory and market access issues. These differences have made it difficult for many investors to make decisions about entering the market with confidence. The situation should improve as more biosimilars reach the market, their benefits become embedded in healthcare systems, and regulatory pathways […]

10th September 2018

Software solutions hold the key to laboratory automation

The idea to automate laboratory processes is not a new concept. Equipment containing at least some form of automation has been developed since as early as the second half of the 19th century. It certainly isn’t surprising that scientists have long sought to automate experimental processes, as any laboratory scientist can attest, many of the […]